Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies

In the last decade there has been tremendous effort in offering better therapeutic management strategies to patients with hematologic malignancies. These efforts have ranged from biological to clinical approaches and resulted in the rapid development of new approaches. The main “problem” that comes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Constantinescu, Catalin, Pasca, Sergiu, Zimta, Alina-Andreea, Tat, Tiberiu, Rus, Ioana, Teodorescu, Patric, Iluta, Sabina, Tanase, Alina, Colita, Anca, Sigurjonsson, Olafur, Einsele, Hermann, Tomuleasa, Ciprian
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Perspective
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565707/
https://ncbi.nlm.nih.gov/pubmed/32911829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092903
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados